McIlrath & Eck’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $264K | Sell |
2,198
-3,994
| -65% | -$461K | 0.02% | 206 |
|
|
2025
Q4 | $652K | Buy |
6,192
+152
| +3% | +$14.3K | 0.06% | 78 |
|
|
2025
Q3 | $507K | Buy |
6,040
+421
| +7% | +$34.7K | 0.05% | 87 |
|
|
2025
Q2 | $445K | Buy |
5,619
+476
| +9% | +$37.8K | 0.05% | 86 |
|
|
2025
Q1 | $462K | Buy |
5,143
+101
| +2% | +$9.43K | 0.06% | 80 |
|
|
2024
Q4 | $502K | Sell |
5,042
-25
| -0.5% | -$2.58K | 0.06% | 76 |
|
|
2024
Q3 | $575K | Buy |
5,067
+162
| +3% | +$19.2K | 0.07% | 67 |
|
|
2024
Q2 | $607K | Buy |
4,905
+432
| +10% | +$55.6K | 0.09% | 62 |
|
|
2024
Q1 | $590K | Buy |
4,473
+354
| +9% | +$43.6K | 0.09% | 60 |
|
|
2023
Q4 | $449K | Buy |
4,119
+94
| +2% | +$9.76K | 0.08% | 75 |
|
|
2023
Q3 | $414K | Buy |
4,025
+277
| +7% | +$29.9K | 0.08% | 75 |
|
|
2023
Q2 | $432K | Sell |
3,748
-265
| -7% | -$30.1K | 0.09% | 67 |
|
|
2023
Q1 | $427K | Buy |
4,013
+213
| +6% | +$23K | 0.1% | 62 |
|
|
2022
Q4 | $422K | Sell |
3,800
-553
| -13% | -$56.5K | 0.11% | 60 |
|
|
2022
Q3 | $375K | Buy |
4,353
+457
| +12% | +$40.8K | 0.1% | 58 |
|
|
2022
Q2 | $355K | Buy |
3,896
+84
| +2% | +$7.45K | 0.11% | 60 |
|
|
2022
Q1 | $313K | Buy |
3,812
+78
| +2% | +$6.15K | 0.09% | 61 |
|
|
2021
Q4 | $286K | Buy |
3,734
+205
| +6% | +$16.3K | 0.08% | 68 |
|
|
2021
Q3 | $265K | Hold |
3,529
| – | – | 0.08% | 67 |
|
|
2021
Q2 | $274K | Buy |
3,529
+162
| +5% | +$12.1K | 0.08% | 67 |
|
|
2021
Q1 | $248K | Buy |
3,367
+977
| +41% | +$72.1K | 0.09% | 60 |
|
|
2020
Q4 | $187K | Sell |
2,390
-78
| -3% | -$5.97K | 0.07% | 65 |
|
|
2020
Q3 | $195K | Buy |
2,468
+86
| +4% | +$6.74K | 0.08% | 53 |
|
|
2020
Q2 | $176K | Buy |
2,382
+490
| +26% | +$36.9K | 0.08% | 52 |
|
|
2020
Q1 | $139K | Buy |
1,892
+21
| +1% | +$1.65K | 0.08% | 53 |
|
|
2019
Q4 | $162K | Buy |
1,871
+724
| +63% | +$59.5K | 0.08% | 55 |
|
|
2019
Q3 | $92K | Hold |
1,147
| – | – | 0.05% | 76 |
|
|
2019
Q2 | $91K | Hold |
1,147
| – | – | 0.05% | 84 |
|
|
2019
Q1 | $91K | Buy |
1,147
+119
| +12% | +$8.9K | 0.05% | 84 |
|
|
2018
Q4 | $75K | Buy |
1,028
+137
| +15% | +$9.67K | 0.05% | 86 |
|
|
2018
Q3 | $60K | Buy |
891
+70
| +9% | +$4.46K | 0.03% | 118 |
|
|
2018
Q2 | $48K | Sell |
821
-492
| -37% | -$27.8K | 0.03% | 121 |
|
|
2018
Q1 | $68K | Sell |
1,313
-1,582
| -55% | -$85.4K | 0.04% | 109 |
|
|
2017
Q4 | $155K | Buy |
+2,895
| New | +$160K | 0.09% | 61 |
|
Other funds holding MRK
VCM
VPM
McIlrath & Eck's MRK Position: Q1 2026 in Review
McIlrath & Eck reduced its Merck (MRK) stake by 65% in Q1 2026, selling an estimated $461K and leaving 2,198 shares worth $264K. The position accounts for 0.02% of the portfolio, ranked #206.
McIlrath & Eck first reported a position in MRK in Q4 2017 and has held it in 34 quarters since. The position peaked at $652K in Q4 2025. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- McIlrath & Eck held 2,198 shares of Merck worth $264K as of Q1 2026.
- McIlrath & Eck sold 3,994 Merck shares in Q1 2026, an estimated $461K.
- Merck made up 0.02% of McIlrath & Eck's portfolio in Q1 2026, its #206 holding.
- McIlrath & Eck first reported a position in Merck in Q4 2017 and has held it in 34 quarters since.
- McIlrath & Eck's Merck position peaked at $652K in Q4 2025.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.